A need for a coordinated EU action on psychedelic therapies

On 24th April, our Founder participated in the EC DG SANTE’s stakeholder event – “A comprehensive approach to mental health” and pitched for an EU-level coordination action to help member states prepare for the roll-out of psychedelic medicines. On this occasion, PAREA submitted concrete ideas on how to make this happen that you can access here.

Previous
Previous

Revision of the EU pharmaceutical legislation

Next
Next

Third issue of PAREA EU Insights newsletter